![TruLaw FDA Warning Image](https://trulaw.com/wp-content/uploads/2022/11/TruLaw-FDA-Warning-Image-768x432.jpg)
FDA warns – Abbott Diabetes Care Inc. recalls three lots of sensors associated with the FreeStyle Libre 3 Continuous Glucose Monitoring System after reports of inaccurate readings
On Thursday, the FDA notified the public of a recall initiated by Abbott Diabetes Care Inc. of three lots of its FreeStyle Libre 3 sensor, which is a component of the company’s FreeStyle Libre 3 Continuous Glucose Monitoring System. The company says that the implicated